These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 28375079)

  • 1. How should the applications of genome editing be assessed and regulated?
    Fears R; Ter Meulen V
    Elife; 2017 Apr; 6():. PubMed ID: 28375079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR plants now subject to tough GM laws in European Union.
    Callaway E
    Nature; 2018 Aug; 560(7716):16. PubMed ID: 30065322
    [No Abstract]   [Full Text] [Related]  

  • 3. A Crispr Future for Gene-Editing Regulation: a Proposal for an Updated Biotechnology Regulatory System in an Era of Human Genomic Editing.
    Tomlinson T
    Fordham Law Rev; 2018 Oct; 87(1):437-83. PubMed ID: 30296034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meeting report of the OECD conference on "Genome Editing: Applications in Agriculture-Implications for Health, Environment and Regulation".
    Friedrichs S; Takasu Y; Kearns P; Dagallier B; Oshima R; Schofield J; Moreddu C
    Transgenic Res; 2019 Aug; 28(3-4):419-463. PubMed ID: 31309374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Separate product from process: framing the debate that surrounds the potential uptake of new breeding technologies.
    Parry G; Jose S
    Physiol Plant; 2018 Dec; 164(4):372-377. PubMed ID: 29220093
    [No Abstract]   [Full Text] [Related]  

  • 6. Use the patent system to regulate gene editing.
    Parthasarathy S
    Nature; 2018 Oct; 562(7728):486-488. PubMed ID: 30353159
    [No Abstract]   [Full Text] [Related]  

  • 7. CRISPR-Cas in Medicinal Chemistry: Applications and Regulatory Concerns.
    Duardo-Sanchez A
    Curr Top Med Chem; 2017; 17(30):3308-3315. PubMed ID: 29231142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The Washington summit: orange light for genome editing?].
    Jordan B
    Med Sci (Paris); 2016 Feb; 32(2):217-20. PubMed ID: 26936181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heritable Human Genome Editing: The International Commission Report.
    Adashi EY; Cohen IG
    JAMA; 2020 Nov; 324(19):1941-1942. PubMed ID: 33034647
    [No Abstract]   [Full Text] [Related]  

  • 10. Legal issues regarding gene editing at the beginning of life: an EU perspective.
    De Miguel Beriain I
    Regen Med; 2017 Sep; 12(6):669-679. PubMed ID: 28976851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical application of gene editing: ethical and social issues.
    Ormond KE; Bombard Y; Bonham VL; Hoffman-Andrews L; Howard H; Isasi R; Musunuru K; Riggan KA; Michie M; Allyse M
    Per Med; 2019 Jul; 16(4):337-350. PubMed ID: 31331245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Legality of Embryonic Gene Editing in Australia.
    Taylor-Sands M; Gyngell C
    J Law Med; 2018 Dec; 26(2):356-373. PubMed ID: 30574724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strict EU ruling on gene-edited crops squeezes science.
    Wight AJ
    Nature; 2018 Nov; 563(7729):15-16. PubMed ID: 30377319
    [No Abstract]   [Full Text] [Related]  

  • 14. Revamp of UK CRISPR regulation will require public trust.
    Nature; 2021 Mar; 591(7850):345. PubMed ID: 33727726
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA Regulation of Clinical Applications of CRISPR-CAS Gene-Editing Technology.
    Grant EV
    Food Drug Law J; 2016; 71(4):608-33. PubMed ID: 29140647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What Is Prudent Governance of Human Genome Editing?
    Schweikart SJ
    AMA J Ethics; 2019 Dec; 21(12):E1042-1048. PubMed ID: 31876467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Policy Considerations Regarding Genome Editing.
    Friedrichs S; Takasu Y; Kearns P; Dagallier B; Oshima R; Schofield J; Moreddu C
    Trends Biotechnol; 2019 Oct; 37(10):1029-1032. PubMed ID: 31229272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the potential of genome editing CRISPR-Cas9 technology.
    Singh V; Braddick D; Dhar PK
    Gene; 2017 Jan; 599():1-18. PubMed ID: 27836667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene editing in legal limbo in Europe.
    Nature; 2017 Feb; 542(7642):392. PubMed ID: 28230148
    [No Abstract]   [Full Text] [Related]  

  • 20. Human genome editing: ask whether, not how.
    Hurlbut JB
    Nature; 2019 Jan; 565(7738):135. PubMed ID: 30602779
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.